– European health regulator said on Thursday it was assessing a marketing authorisation application for GSK-Vir Biotechnology’s monoclonal antibody treatment for COVID-19 and could give its opinion within two months. …
Tag:
gsk-vir
-
-
By Pushkala Aripaka -The United States has signed contracts worth about $1 billion for doses of the antibody-based COVID-19 treatment from Britain’s GSK and U.S.-based Vir Biotechnology, as countries seek …
-
By Ludwig Burger and Pushkala Aripaka -Britain’s GSK and partner Vir said on Friday their antibody-based COVID-19 drug was shown in a trial to work as well when given as …